[Comparison of brain scintigraphy with 99mTc-pertechnate and 99mTc-citrate].
20 patients with ultimately proven cerebral lesion were studied consecutively with 99mTc-pertechnetate and 99mTc-citrate. A comparison of the brain scans showed neoplastic lesions to be visualized more clearly with 99mTc-citrate, and vascular lesions to be demonstrated better with 99mTc-pertechnetate. Comparative brain scanning utilizing 99mTc-citrate and 99mTc-pertechnetate facilitates the differentiation between acute brain infarcts and neoplastic lesions which is difficult or may be impossible by cerebral computer tomography. The reduced radiation exposure from 99mTc-citrate and its superior usefulness in the visualization of neoplastic lesions suggest its use as the primary brain scanning agent.
D001927:Brain Diseases / Q000000981:diagnostic imaging*; D001932:Brain Neoplasms / Q000000981:diagnostic imaging; D002951:Citrates; D004678:Encephalomalacia / Q000000981:diagnostic imaging; D005910:Glioma / Q000000981:diagnostic imaging; D006407:Hematoma, Epidural, Cranial / Q000000981:diagnostic imaging; D006801:Humans; D008577:Meningeal Neoplasms / Q000000981:diagnostic imaging; D008579:Meningioma / Q000000981:diagnostic imaging; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011877:Radionuclide Imaging; D013667:Technetium
D002951:Citrates; D013667:Technetium
Vergleichende Hirnszintigraphie mit 99mTc-Pertechnetat und 99mTc-Zitrat.